"Jewish Hospital, part of UofL Health, is an internationally renowned, high-tech tertiary referral center, developing leading-edge advancements in hand and microsurgery, heart and lung care, orthopedics and sports medicine, neuroscience, organ transplantation and outpatient care. The hospital is the site of the world's first successful hand transplant and AbioCor® implantable replacement heart procedures, in addition to the first trial of adult cardiac stem cells in chronic heart failure. Jewish Hospital continues to be recognized for its specialized heart care procedures, including the implantation of ventricular assist devices (VAD), and transcatheter aortic valve replacement (TAVR). The UofL Health - Trager Transplant Center is in a selec"

During the past decade, Jewish Hospital conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 75 clinical trials were completed, i.e. on average, 43.9% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 59 clinical trials were completed. i.e. 81.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jewish Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 86 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 25 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 17 trials sponsored and "Abbott Medical Devices" with 17 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jewish Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 87 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Thoratec Corporation" with 5 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Jewish Hospital" are "Heart Failure" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Lung Cancer" (7 trials), "Recurrent Ovarian Carcinoma" (7 trials) and "Stage IV Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Jewish Hospital" in a lesser frequency.

Most popular intervention types in "Jewish Hospital" are "Drug" (144 trials), "Other" (114 trials), "Biological" (88 trials), "Procedure" (55 trials) and "Device" (39 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (41 trials), "Computed Tomography" (31 trials), "Nivolumab" (30 trials) and "Questionnaire Administration" (28 trials). Other intervention names were less common.

The vast majority of trials in "Jewish Hospital" are 205 trials for "All" genders, 26 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Jewish Hospital". 1 are not yet recruiting, 61 are recruiting, 91 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Jewish Hospital, 4 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Jewish Hospital, 5 "Phase 1" clinical trials were conducted, 97 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 37 trials that are defined as “Not Applicable".

Jewish Hospital has several departments that took part in Clinical trials: "James Graham Brown Cancer Center" - 308 trials, "Frazier Rehabilitation and Neuroscience Institute" - 8 trials, "Louisville Radiation Oncology Center at Caritas Regional Cancer Center" - 4 trials, "University of Louisville Kidney Disease Program" - 3 trials, "Owsley Brown Frazier Cancer Center" - 3 trials, "Jewish Hospital - Rudd Heart and Lung Institute" - 3 trials, "Bluegrass Cardiology" - 2 trials, "U of L - Physicians Pulmonology; Dept of Neuroradiology and Dept of Diagnostic Radiology" - 2 trials